SC
ANGO icon

Shay Capital’s AngioDynamics ANGO Stock Holding History

Shay Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-75,000
Closed -$584K – 312
2024
Q3 		$584K Sell
75,000
-75,000
-50% -$542K 0.08% 145
2024
Q2 		$908K Buy
150,000
+25,000
+20% +$154K 0.13% 106
2024
Q1 		$734K Buy
125,000
+50,000
+67% +$297K 0.11% 144
2023
Q4 		$588K Buy
+75,000
New +$520K 0.12% 120
2023
Q2 		– Sell
-40,000
Closed -$414K – 412
2023
Q1 		$414K Buy
+40,000
New +$512K 0.08% 201
2021
Q4 		– Sell
-40,000
Closed -$1.04M – 478
2021
Q3 		$1.04M Buy
+40,000
New +$1.07M 0.13% 162

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Shay Capital's ANGO Position: Q4 2024 in Review

Shay Capital sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 75,000 shares — an estimated $584K sold.

Shay Capital first reported a position in ANGO in Q3 2021 and held it in 6 quarters. The position peaked at $1.04M in Q3 2021. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Shay Capital reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Shay Capital sold 75,000 AngioDynamics shares in Q4 2024, an estimated $584K.
  • Shay Capital first reported a position in AngioDynamics in Q3 2021 and held it in 6 quarters.
  • Shay Capital's AngioDynamics position peaked at $1.04M in Q3 2021.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Shay Capital's 13F filing for Q4 2024, filed 14 Feb 2025.